About PSM
“5 Ways” consumer bookmark
Download our “5 Ways” Consumer Bookmark for a quick reference about how to protect yourself from counterfeit medicine.
[...]Policy Resolution, January 8, 2020
The following policy resolution was passed unanimously at the Jan. 8, 2020 board meeting in Washington DC. The governing board of the Partnership for Safe Medicines votes today to reiterate that the Partnership is organized to focus entirely of the safety of medicine as it travels through the supply chain, as we have since our…
[...]PSM Statement on the passage of S.3201, which extends the DEA’s temporary scheduling of fentanyl-related substances as Schedule I for 15 months.
The Partnership for Safe Medicines (PSM) stands with our law enforcement partners in commending the U.S. Senate and the U.S. House of Representatives for their swift passage of S.3201, which would extend the DEA’s temporary scheduling of fentanyl-related substances to be Schedule I controlled substances for an additional 15 months. Without this reauthorization, criminals could…
[...]HHS Announces Dangerous Draft Regulations for Importing Drugs from Canada
Partnership for Safe Medicines Statement on Proposed Regulations to Import Prescription Medicines from Canada Washington, D.C. (December 18, 2019) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to today’s announcement by the Trump Administration and the proposed regulations to allow importation of prescription medicines: “Citizens of…
[...]PSM’s Executive Director Speaks on Morning Wakeup with Dave Akerly to Warn Michigan Residents about the Dangers of Drug Importation
PSM’s Executive Director Shabbir Safdar spoke with Dave Akerly on WILS in Lansing, Michigan about the importation proposal currently being debated in the Michigan House of Representatives. Safdar was enroute to the Michigan State House to participate in hearings on drug importation being held there. Here why our Executive Director has travelled to Michigan to testify at their drug importation hearing.
[...]How do you test whether a medication is legitimate?
Testing medicine for legitimacy is a complicated process. Across 24 different prescription medicines, the average cost to test a single dose is $2,750. However, ensuring that a batch of 100 pills is safe requires testing at least 22 pills. To learn more about this topic, read “Dollars and Sense: An Examination of the Cost Effectiveness of Pharmaceutical Importation” by Dr. Kristina Acri nee Lybecker at https://safedr.ug/DrAcri.
[...]Bloomberg Misses The Mark In Its Article About Drug Importation Advocacy
In case you missed it, Bloomberg’s Ben Elgin has published an “in-depth” piece on the connection between PhRMA and the Partnership for Safe Medicines. However, this has been public and widely reported on for years. More concerningly, the story misses the broader point about the clear safety concerns of foreign drug importation. Over the past…
[...]PSM, Partners Host Fall 2019 Congressional Briefings About Counterfeit Drug Dangers
On September 24, 2019, the Partnership for Safe Medicines and 19 partner organizations held two congressional briefings about the real dangers counterfeit drugs pose to Americans, offering a clear picture of why importation cannot solve the problem of high drug prices in the U.S.:
Canada does not have enough prescription drugs to share with U.S.patients, and organized crime is poised to expand the counterfeit drug trade into the U.S. to bridge the gap without regard for the health and safety of U.S. residents. “The money to be made is far too great to worry about human life.”
[...]Myth: We are getting the same drugs Canadians take
In 2014, during a two-year period when Maine was experimenting with drug importation, the president of Maine’s Pharmacy Association purchased medications from an online pharmacy for testing. The drugs he received were not approved for the Canadian or U.S. markets. Worse, they were poor quality: two of them were the wrong strength, and the other was contaminated.
[...]Two Studies Confirm Drug Importation Would Decimate The Canadian Drug Supply
Two new studies recently published in Canadian Health Policy each reached the same conclusion: legalizing drug importation in the U.S. would cause catastrophic damage to the Canadian drug supply…
[...]